MelApp - Melanoma Staging for Android

11 things about MelApp - Melanoma Staging

1. Meeter Congressi and Melanoma Unit shall not be held liable for any damages arising out of the use of the information contained in MelApp, for any injury or damage to persons or property resulting from the use of the app or any of its features, including lost profits, punitive or exemplary damages, since it serves only as guidance support for the AJCC tables.

2. Meeter Congressi and Melanoma Unit have developed MelApp based on the information contained in the AJCC Cancer Staging Manual.

3. By simply selecting items from a drop-down menu, set according to the criteria of the AJCC tables, MelApp also allows you to identify the three T-N-M parameters.

4. MelApp is developed by Meeter Congressi in collaboration with Melanoma Unit - University of Campania "Luigi Vanvitelli", Prof.

5. Identify rapidly and accurately T, N, M parameters for melanoma staging, guiding you through the complex AJCC tables.

6. By cross-referencing the three values thus obtained, the final result, parameter S, will help you determine the stage of the lesion as identified by the AJCC tables and suggest possible follow-up indications.

7. In 2018, the eighth edition of the American Joint Committee on Cancer (AJCC) T-N-M classification came into effect to improve the prognostic stratification of melanoma.

8. MelApp is a supporting app that helps you navigate quickly and accurately through the complex AJCC tables.

9. We are not responsible for the academic accuracy or thoroughness of the information contained in the AJCC Cancer Staging Manual.

10. Correct staging of melanoma is of fundamental importance for the correct treatment of patients suffering from this condition.

11. MelApp should not be used for the diagnosis or treatment of melanoma.